Related Experiment Video
Updated: Oct 31, 2025

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Therapeutic Plasma Exchange in Children - Experience From a Tertiary Care Center
Rufaida Mazahir1, Kanav Anand2, P K Pruthi2
1Division of Pediatric Nephrology, Department of Pediatrics, Institute of Child Health, Sir Ganga Ram Hospital, New Delhi. Correspondence to: Dr Rufaida Mazahir, Division of Pediatric Nephrology, Department of Pediatrics, Institute of Child Health, Sir Ganga Ram Hospital, Old Rajender Nagar, New Delhi 110 060. rufaidamazahir@gmail.com.
Insights
Therapeutic plasma exchange (TPE) is safe and effective in children for various conditions, including renal and neurological diseases. Most pediatric patients showed significant recovery with minimal complications during TPE procedures.
Area of Science:
- Pediatric Nephrology
- Pediatric Neurology
- Apheresis Medicine
Background:
- Therapeutic plasma exchange (TPE) is a critical extracorporeal treatment for various pediatric conditions.
- Assessing TPE's safety and efficacy in pediatric populations is essential for guiding clinical practice.
- Limited data exists on TPE outcomes specifically in children across diverse indications.
Purpose of the Study:
- To evaluate the safety, efficacy, and clinical outcomes of therapeutic plasma exchange (TPE) in pediatric patients.
- To identify common indications and patient demographics undergoing TPE in a pediatric setting.
- To analyze the types and frequency of complications associated with TPE in children.
Main Methods:
- Retrospective analysis of hospital records for pediatric patients (<=18 years) who underwent TPE.
- Data collection spanned from August 2011 to July 2018.
- TPE was performed using membrane plasma separation, with specific replacement fluids noted for different indications.
Main Results:
- 46 children underwent 293 TPE sessions; renal diseases (52.2%) and neurological illnesses (36.9%) were primary indications.
- Atypical hemolytic uremic syndrome (aHUS) was the most frequent diagnosis (34.8%).
- 86.9% of patients achieved complete or partial recovery, with minor complications like blood pressure fluctuations occurring in 7.1% of sessions.
Conclusions:
- Therapeutic plasma exchange (TPE) is a safe and effective treatment modality for pediatric patients with both renal and non-renal conditions.
- TPE demonstrates positive outcomes even in younger children, supporting its use across a wide pediatric age range.
- The study reinforces the utility of TPE in managing severe pediatric diseases, with a favorable safety profile.
Objective:
To assess the safety, efficacy and outcomes of therapeutic plasma exchange (TPE) in children.
Methods:
Data were retrieved from hospital records for all children £18 years who underwent TPE between August, 2011 and July, 2018.
Results:
46 children [median (range) age 96 (8-204) months] underwent 293 sessions of TPE by membrane plasma separation technique. Renal disease was the commonest indication (24, 52.2%) followed by neurological illnesses (17; 36.9%). 36 (78.2%) patients belonged to American Society for Apheresis category I. Overall, the most common indication was atypical hemolytic uremic syndrome (aHUS) (16; 34.8%). Fresh frozen plasma plus albumin was used as replacement fluid in aHUS, while albumin was used in others. 40 (86.9%) patients had complete/partial recovery while six did not show any sign of recovery. Complications were seen in 21 (7.1%) sessions; majority of which were minor in the form of blood pressure fluctuations.
Conclusion:
TPE can be performed safely and effectively for renal and non-renal indications, even in small children.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy
Pharmacokinetics in Pediatric Patients: Drug Distribution
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

